Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Differential diagnosis of calciphylaxis in chronic dialysis patients.

Musso CG, Enz PA, Kowalczuk A, Cozzolino M, Brandenburg V, Nigwekar S.

Int Urol Nephrol. 2020 Feb 1. doi: 10.1007/s11255-020-02388-z. [Epub ahead of print] No abstract available.

PMID:
32008200
2.

Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis.

Brandenburg VM, Sinha S, Torregrosa JV, Garg R, Miller S, Canals AZ, Bahr D, Joubert PH, Salcedo C, Carroll KJ, Gold A, Perelló J.

J Nephrol. 2019 Oct;32(5):811-821. doi: 10.1007/s40620-019-00631-0. Epub 2019 Aug 10.

PMID:
31401795
3.

Review: update on the management of calciphylaxis.

Seethapathy H, Brandenburg VM, Sinha S, El-Azhary RA, Nigwekar SU.

QJM. 2019 Jan 1;112(1):29-34. doi: 10.1093/qjmed/hcy234. Review.

PMID:
30304522
4.

Calciphylaxis.

Nigwekar SU, Thadhani R, Brandenburg VM.

N Engl J Med. 2018 Jul 26;379(4):399-400. doi: 10.1056/NEJMc1807324. No abstract available.

PMID:
30044942
5.

Calciphylaxis.

Nigwekar SU, Thadhani R, Brandenburg VM.

N Engl J Med. 2018 May 3;378(18):1704-1714. doi: 10.1056/NEJMra1505292. Review. No abstract available.

PMID:
29719190
6.

Calciphylaxis: Another Piece of the Puzzle.

Brandenburg VM, Sinha S.

Am J Nephrol. 2017;46(5):427-428. doi: 10.1159/000484545. Epub 2017 Nov 9. No abstract available.

7.

K-alcification Protection in Dialysis Patients: The Underestimated Phenomenon of Vitamin K Deficiency.

Ketteler M, Brandenburg VM.

J Am Soc Nephrol. 2017 Jun;28(6):1667-1668. doi: 10.1681/ASN.2017020180. Epub 2017 Apr 3. No abstract available.

8.

Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients - Data from the German Calciphylaxis Registry.

Rothe H, Brandenburg V, Haun M, Kollerits B, Kronenberg F, Ketteler M, Wanner C.

PLoS One. 2017 Feb 17;12(2):e0172407. doi: 10.1371/journal.pone.0172407. eCollection 2017.

9.

Hypothesis: Phytate is an important unrecognised nutrient and potential intravenous drug for preventing vascular calcification.

Joubert P, Ketteler M, Salcedo C, Perello J.

Med Hypotheses. 2016 Sep;94:89-92. doi: 10.1016/j.mehy.2016.07.005. Epub 2016 Jul 12.

PMID:
27515210
10.

Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis?

Brandenburg VM, Evenepoel P, Floege J, Goldsmith D, Kramann R, Massy Z, Mazzaferro S, Schurgers LJ, Sinha S, Torregrosa V, Ureña-Torres P, Vervloet M, Cozzolino M; ERA-EDTA Working Group on CKD-MBD and EUCALNET.

Nephrol Dial Transplant. 2016 Aug;31(8):1211-9. doi: 10.1093/ndt/gfw025. Epub 2016 Mar 22.

PMID:
27005994
11.

Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry.

Brandenburg VM, Kramann R, Rothe H, Kaesler N, Korbiel J, Specht P, Schmitz S, Krüger T, Floege J, Ketteler M.

Nephrol Dial Transplant. 2017 Jan 1;32(1):126-132. doi: 10.1093/ndt/gfv438.

PMID:
26908770
12.

Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet).

Brandenburg V, Adragao T, van Dam B, Evenepoel P, Frazão JM, Ketteler M, Mazzaferro S, Urena Torres P, Ramos R, Torregrosa JV, Cozzolino M.

Clin Kidney J. 2015 Oct;8(5):567-71. doi: 10.1093/ckj/sfv056. Epub 2015 Jul 6. Review.

13.

Vascular calcification in chronic kidney disease: an update.

Schlieper G, Schurgers L, Brandenburg V, Reutelingsperger C, Floege J.

Nephrol Dial Transplant. 2016 Jan;31(1):31-9. doi: 10.1093/ndt/gfv111. Epub 2015 Apr 26.

PMID:
25916871
14.

Evolving calciphylaxis--what randomized, controlled trials can contribute to the capture of rare diseases.

Ketteler M, Biggar PH.

Clin J Am Soc Nephrol. 2015 May 7;10(5):726-8. doi: 10.2215/CJN.03350315. Epub 2015 Apr 17. No abstract available.

15.

From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD.

Brandenburg VM, D'Haese P, Deck A, Mekahli D, Meijers B, Neven E, Evenepoel P.

Pediatr Nephrol. 2016 Feb;31(2):195-206. doi: 10.1007/s00467-015-3069-7. Epub 2015 Mar 4. Review.

PMID:
25735207
16.

[Calciphylaxis].

Brandenburg VM, Martin H, Sohn CM, Ketteler M.

Dtsch Med Wochenschr. 2015 Mar;140(5):347-51. doi: 10.1055/s-0041-100834. Epub 2015 Mar 3. Review. German.

PMID:
25734678
17.

Calcific uremic arteriolopathy: a call for action.

Brandenburg VM, Cozzolino M, Mazzaferro S.

Semin Nephrol. 2014 Nov;34(6):641-7. doi: 10.1016/j.semnephrol.2014.09.007. Review.

PMID:
25498382
18.

Integrated image data and medical record management for rare disease registries. A general framework and its instantiation to theGerman Calciphylaxis Registry.

Deserno TM, Haak D, Brandenburg V, Deserno V, Classen C, Specht P.

J Digit Imaging. 2014 Dec;27(6):702-13. doi: 10.1007/s10278-014-9698-8.

19.

Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorder.

Brandenburg VM, Sinha S, Specht P, Ketteler M.

Pediatr Nephrol. 2014 Dec;29(12):2289-98. doi: 10.1007/s00467-013-2746-7. Epub 2014 Jan 29. Review.

PMID:
24474577
20.

Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy.

Kramann R, Brandenburg VM, Schurgers LJ, Ketteler M, Westphal S, Leisten I, Bovi M, Jahnen-Dechent W, Knüchel R, Floege J, Schneider RK.

Nephrol Dial Transplant. 2013 Apr;28(4):856-68. doi: 10.1093/ndt/gfs466. Epub 2012 Dec 6.

PMID:
23223222

Supplemental Content

Loading ...
Support Center